Twist Bioscience Corp. (TWST)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$124.72-3.10%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TWST
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 431.8 | 376.6 | 313.0 | 245.1 | 203.6 | 132.3 | 90.1 | 54.4 |
| Cost of Revenues | 207.4 | 185.6 | 179.6 | 155.4 | 119.3 | 80.6 | 61.4 | 47.4 |
| Operating Expenses & Income | ||||||||
| Selling, General & Admin | 290.3 | 247.0 | 218.4 | 189.7 | 212.9 | 135.9 | 103.3 | 80.1 |
| R&D Expenses | 71.9 | 80.3 | 90.9 | 106.9 | 120.3 | 69.1 | 43.0 | 35.7 |
| Operating Income | (145.0) | (136.3) | (220.8) | (217.2) | (234.8) | (152.7) | (140.1) | (108.9) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | — | 0.0 | 0.0 | 0.1 | 0.4 | 0.8 | 1.3 |
| Interest & Investment Income | 8.0 | 11.4 | 15.3 | 14.4 | 3.1 | 0.4 | 1.5 | 3.0 |
| Net Interest Expenses | — | — | — | (14.4) | (3.0) | (0.1) | (0.7) | (1.7) |
| Asset Writedown | — | — | 44.9 | 6.8 | 0.0 | — | — | — |
| EBT, Incl. Unusual Items | (135.9) | (77.0) | (208.2) | (203.5) | (228.3) | (154.0) | (139.5) | (107.4) |
| Income Tax Expense | 0.9 | 0.7 | 0.6 | 1.2 | (10.4) | (1.9) | 0.4 | 0.3 |
| Net Income | ||||||||
| Net Income | (136.7) | (77.7) | (208.7) | (204.6) | (217.9) | (152.1) | (139.9) | (107.7) |
| Per Share | ||||||||
| Basic EPS | (2.19) | (1.30) | (3.60) | (3.60) | (4.04) | (3.15) | (3.57) | — |
| Diluted EPS | (2.19) | (1.30) | (3.60) | (3.60) | (4.04) | (3.15) | (3.57) | — |
| Revenue per Share | 6.92 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 62.4 | 59.8 | 58.0 | 56.9 | 53.9 | 48.3 | 39.2 | — |
| Diluted Weighted Avg Shares | 62.4 | 59.8 | 58.0 | 56.9 | 53.9 | 48.3 | 39.2 | — |
| Supplemental | ||||||||
| EBITDA | — | (111.4) | (189.4) | (187.8) | (218.3) | (143.0) | (133.4) | (102.8) |
| EBIT | (145.0) | (136.3) | (220.8) | (217.2) | (234.8) | (152.7) | (140.1) | (108.9) |
| Effective Tax Rate | -0.6% | — | — | -0.6% | 4.6% | 1.3% | -0.3% | -0.3% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.